Search
Migraine Clinical Trials in Stanford, CA
A listing of 3 Migraine clinical trials in Stanford, CA actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Migraine
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The city of Stanford, California, currently has 3 active clinical trials seeking participants for Migraine research studies.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Kids and Teens Migraine Clinical Study
Recruiting
We are looking for adolescents who experience migraines to take part in a clinical trial. No health insurance is required. The study medicine and any trial-related procedures will be provided.
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Migraine Without Aura
Featured Trial
Migraine Clinical Trial
Recruiting
Over 39 million people in the US suffer from migraines. You are not alone! If you are struggling with migraines, consider joining a clinical trial to help us study potential new treatment options. All eligible participants will receive no-cost study-related care and study medication. You may also receive compensation for your study-related time and/or travel.
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Migraine Without Aura
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Analysis of Headache Chronification with Imaging, Deep Phenotyping, and Proteomics
Recruiting
Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help explain this process.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/06/2024
Locations: Stanford University School of Medicine, Stanford, California
Conditions: Chronic Daily Headache, Chronic Migraine
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
Recruiting
Exparel has a proven efficacy in providing pain relief for up to 72 hours with a single-dose administration at surgical sites. The study aims to evaluate the effectiveness of endoscopically-guided injection of Exparel (Bupivacaine) for the treatment of craniofacial pain. This study would be conducted in a prospective, randomized, double-blinded, placebo- controlled, and cross-over fashion. We aim to investigate whether the administration of Exparel (Bupivacaine) to the lateral nasal wall may pos... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
04/16/2024
Locations: Peter H Hwang, Stanford, California
Conditions: Craniofacial Pain, Migraine, Cluster Headache, Trigeminal Autonomic Cephalgia, Sphenopalatine Ganglion Neuralgia, Paroxysmal Hemicrania
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
Recruiting
This study will unpack the behavioral intervention for migraine and determine the optimum combinations. In addition, the study will test preference and self-selection effects during the trial.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: Stanford University, Stanford, California
Conditions: Migraine, Headache, Chronic Migraine, Headache Disorders
1 - 3 of 3